PQQ

Pyrroloquinoline quinone (PQQ) is a redox-active quinone that works as an electron-carrying cofactor and antioxidant. It was first recognized in bacteria in the 1960s as a novel cofactor distinct from the nicotinamide and flavin systems, and its structure was characterized in the late 1970s. In microbes it serves as the prosthetic group of quinoproteins such as certain glucose and alcohol dehydrogenases, enzymes that use PQQ to shuttle electrons during metabolism.

PQQ occurs widely at low levels in fruits, vegetables, fermented foods, and human milk, and it is present in mammalian tissues, which has prompted long-running discussion about whether it should be considered a vitamin. A 2003 report proposed it as a new mammalian vitamin, a claim that was later disputed, and it is now more often described as a beneficial dietary factor supporting long-term health rather than an essential nutrient. Commercially it is marketed as a dietary supplement, frequently promoted for energy, cognitive, and cardiovascular support ^[2].

Much of the scientific interest in PQQ centers on mitochondria. Laboratory studies show that PQQ can stimulate mitochondrial biogenesis, the cellular process of building new mitochondria, and small human trials have reported changes in markers linked to this process ^[1][2][3]. In a controlled study of untrained men, PQQ supplementation raised levels of PGC-1-alpha, a key regulator of mitochondrial biogenesis, although it did not clearly improve aerobic performance ^[2]. As a supplement rather than an approved medicine, PQQ is regulated as a food or dietary ingredient in most markets, and evidence for its health claims in humans remains limited ^[3].

PQQ has an excellent safety record, with no serious problems reported in human trials up to 20 mg a day. Bigger doses (40 mg and up) can bring a passing headache or some nausea, especially on an empty stomach. No serious contraindications are known, though if you're on blood thinners or chemo, run it by a doctor since its redox activity could in theory interfere. Legal worldwide as an OTC supplement, and not scheduled anywhere. Pregnant or breastfeeding folks should skip it for lack of data.

Pyrroloquinoline quinone, abbreviated PQQ, is a small redox active ortho quinone that was first identified in the 1960s and structurally characterized in the late 1970s as a novel cofactor in certain bacterial dehydrogenase enzymes, distinct from the previously known flavin and nicotinamide cofactors. Its discovery expanded the recognized classes of biological redox cofactors, and for a period it was investigated as a possible vitamin for higher organisms, a claim that remains debated. Later research focused on its presence in foods and human tissues and on its apparent ability to influence mitochondrial biogenesis and cellular energy metabolism, which drove its adoption as a dietary supplement.

PQQ is popular among mitochondrial health and longevity enthusiasts, who value it for its purported ability to support the formation of new mitochondria and to complement coenzyme Q10, and it is frequently marketed alongside that compound. Its reputation is buoyed by intriguing cell and animal data and by a small number of human studies suggesting effects on energy, oxidative markers, and cognition. Nonetheless, critical reviewers emphasize that human evidence remains limited and often industry associated, that its status as an essential nutrient is unresolved, and that claimed benefits should be regarded as promising but not firmly established.